COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE

被引：55

作者：

INABA, T ^{[1
]}

VINKS, A ^{[1
]}

OTTON, SV ^{[1
]}

KALOW, W ^{[1
]}

机构：

[1] UNIV TORONTO,FAC MED,DEPT PHARMACOL,TORONTO M5S 1AB,ONTARIO,CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 33卷 / 03期

关键词：

D O I：

10.1038/clpt.1983.51

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：394 / 399

页数：6

共 17 条

[1] ALVAN G, 1982, LANCET, V1, P333
[2] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[3] EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER
DAVIES, DS
KAHN, GC
MURRAY, S
BRODIE, MJ
BOOBIS, AR
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) : 89 - 91
[4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[5] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
EICHELBAUM, M
BERTILSSON, L
SAWE, J
ZEKORN, C
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
[6] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[7] GAS-LIQUID-CHROMATOGRAPHIC ELECTRON-CAPTURE DETERMINATION OF SOME MONOSUBSTITUTED GUANIDO-CONTAINING DRUGS
ERDTMANSKY, P
GOEHL, TJ
[J]. ANALYTICAL CHEMISTRY, 1975, 47 (04) : 750 - 752
[8] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[9] DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS
INABA, T
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 218 - 223
[10] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE
INABA, T
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 547 - 549

← 1 2 →